Re: Toxicity

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jonzobot

Rank: President [?]

Points: 2527 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Toxicity

in response to

Toxicity

jonzobot

posted on Mar 22, 2023 03:44PM

I don't know if anyone has noticed, but it looks like the trial that was suspended for toxicity has now resumed with some changes.

https://clinicaltrials.gov/ct2/show/NCT05111561

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply